You have been contacted to analyze the financial performance of two firms listed on the Ghana Stock Exchange . It is required that you provide financial ratios and trend/horizontal analysis

for the two firms, contrasting and comparing them. Furthermore, you are asked to identify the effects of the COVID-19 pandemic on the financial performance of these firms. Note that the impact of COVID-19 was felt by firms operating in Ghana during the 2020 financial year. The categories of ratios to be computed are shown in the table below.

Note:

Non-interest expenses capture all expenses except interest expenses

The report should be structured as follows:

1. Cover Page, which should contain:

a) A relevant title for the report.

b) Contain the financial ratios of the firms and the trend of these ratios (2017 to 2022)

presented in formatted tables and or figures.

c) Contain a critical analysis of the ratios and their trends.

d) Compare and contrast the performances of the firms under profitability, liquidity,

solvency, and efficiency.

e) Identify the impact of COVID-19 on the financial performance of the firms

f) Contain a critical discussion of the implications of the findings.

b) Provide the financial statements used for the calculation of the financial ratios. These should be put in another appendix

.Below are the statements we working with

Income Statement of Unilever 2017

Balance Sheet of Unilever 2017

Income Statement of Unilever 2018

Balance Sheet of Unilever 2018

Income Statement of Unilever 2019

Balance Sheet of Unilever 2019

Balance Sheet of Intravenous Infusion Plc 2017

Income Statement of Intravenous Infusion PlC 2017

Balance Sheet of Intravenous Infusion Plc 2018

Income Statememt of Intravenous Infusion Plc 2018

Balance Sheet of Intravenous Infusion Plc 2019

Income Statement of Intravenous Infusion Plc 2019

Statement of comprehensive income for the year ended 31 December |All amounts are expressed in thousands of Ghana cedis) Statement of comprehensive income for the year ended 31 December IAll amounts are expressed in thousands of Ghana cedis! Statement of financial position as at 31 December IAll amsunte bra aviubecad in thnizesnde nt fihano radiel Note Revenue Cost of sales Gross profit/(loss) Distribution expenses Brand and marketing investment Administrative expenses Restructuring costs Impairment allowance on trade \& other receivables Other income 35cli) 11a Operating loss Finance income Finance costs 121214a100[5,608][27,559}[22,830][50,389]571[11,603](216,647]56,331[160,316] Other comprehensive income Items that will not be reclassified to profit or loss Actuarial gain 17b Related tax Other comprehensive income, net of tax Total comprehensive income 2020 Annual reports \& Financial Statements Rediscovering Our Greatness In A Globally Challenging Environment Statement of financial position as at 31 December 2020 Uniles The financial statements were approved by the Board of Directors on 23 March 2021 and signed on their behalf by: The notes on pages 34 to 78 form an integral part of these financial statements. Intravenous Infusions PIc Statement of financial position As at 31 December 2017 The accompanying notes form an integral part of the financial statements. Intravenous Infusions Plc Statement of profit \& loss and other comprehensive income For the year ended 31 December 2017 Intravenous Infusions Plc Statement of financial position As at 31 December 2018 Current assets \begin{tabular}{lrrr} Imventory & 12 & 4,462,162 & 4,309,639 \\ Trade and other receivables & 13 & 12,436,678 & 9,900,616 \\ Cash and cash equivalent & 14 & 1,839,610 & 228,282 \\ \hline Total current asset & & 18,738,450 & 14,438,537 \\ \hline Total assets & & 26,550,536 & 20,518,106 \\ \hline \end{tabular} Current liabilities The accompanying notes form an integral part of the financial statements. Intravenous Infusions Plc Statement of profit & loss and other comprehensive income For the year ended 31 December 2018 The accompanying notes form an integral part of the financial statements. Intravenous Infusions Plc Statement of financial position Intravenous Infusions PIc Statement of profit or loss and other comprehensive income For the year ended 31 December 2019